Fluocinonide in FAPG base: a review of its therapeutic efficacy in inflammatory dermatoses.
D000287:Administration, Topical; D003436:Croton Oil / Q000494:pharmacology; D004342:Drug Hypersensitivity; D004485:Eczema / Q000627:therapeutic use; D005446:Fluocinolone Acetonide / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D007249:Inflammation / Q000139:chemically induced; D014677:Pharmaceutical Vehicles; D011409:Propylene Glycols; D011565:Psoriasis / Q000188:drug therapy; D011832:Radiation Injuries / Q000188:drug therapy; D012871:Skin Diseases / Q000188:drug therapy*; D013259:Steroids, Fluorinated / Q000627:therapeutic use; D014466:Ultraviolet Rays; D014662:Vasoconstrictor Agents / Q000627:therapeutic use
D014677:Pharmaceutical Vehicles; D011409:Propylene Glycols; D013259:Steroids, Fluorinated; D014662:Vasoconstrictor Agents; D005446:Fluocinolone Acetonide; D003436:Croton Oil